CCR2 and neoplasm: Here, using a preclinical orthotopic PDAC tumor model, we provide direct evidence that iIRE treatment induces a CCR2+ TAM-mediated immunosuppressive microenvironment in the residual tumor, ultimately accelerating tumor progression.